{"id":"https://openalex.org/W2096719451","doi":"https://doi.org/10.1136/heartjnl-2011-300646","title":"Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation","display_name":"Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation","alternate_titles":[],"publication_year":2012,"publication_date":"2012-03-15","ids":{"openalex":"https://openalex.org/W2096719451","doi":"https://doi.org/10.1136/heartjnl-2011-300646","mag":"2096719451","pmid":"https://pubmed.ncbi.nlm.nih.gov/22422743","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3308473"},"language":"en","primary_location":{"id":"doi:10.1136/heartjnl-2011-300646","doi":"https://doi.org/10.1136/heartjnl-2011-300646","is_oa":true,"landing_page_url":"https://doi.org/10.1136/heartjnl-2011-300646","pdf_url":"https://heart.bmj.com/content/heartjnl/98/7/573.full.pdf","source":{"id":"https://openalex.org/S191565391","display_name":"Heart","issn_l":"1355-6037","issn":["1355-6037","1468-201X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heart","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2096719451"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://heart.bmj.com/content/heartjnl/98/7/573.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Anuraag R Kansal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anuraag R Kansal","raw_affiliation_strings":["United BioSource Corporation, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United BioSource Corporation, Bethesda, Maryland, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109115729","display_name":"Sonja V. Sorensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sonja V Sorensen","raw_affiliation_strings":["United BioSource Corporation, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United BioSource Corporation, Bethesda, Maryland, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018722015","display_name":"Ray Gani","orcid":"https://orcid.org/0000-0002-2967-3132","observed_orcids":["https://orcid.org/0000-0002-2967-3132"]},"institutions":[{"id":"https://openalex.org/I4210112752","display_name":"Boehringer Ingelheim (United Kingdom)","ror":"https://ror.org/01jnnpe14","country_code":"GB","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210112752"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ray Gani","raw_affiliation_strings":["Boehringer Ingelheim Ltd, Bracknell, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Ltd, Bracknell, UK","institution_ids":["https://openalex.org/I4210112752"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101445453","display_name":"Paul J. Robinson","orcid":"https://orcid.org/0000-0002-3918-4420","observed_orcids":["https://orcid.org/0000-0002-3918-4420"]},"institutions":[{"id":"https://openalex.org/I4210112752","display_name":"Boehringer Ingelheim (United Kingdom)","ror":"https://ror.org/01jnnpe14","country_code":"GB","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210112752"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Robinson","raw_affiliation_strings":["Boehringer Ingelheim Ltd, Bracknell, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Ltd, Bracknell, UK","institution_ids":["https://openalex.org/I4210112752"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Feng Pan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Feng Pan","raw_affiliation_strings":["United BioSource Corporation, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United BioSource Corporation, Bethesda, Maryland, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jonathan M Plumb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jonathan M Plumb","raw_affiliation_strings":["Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088713964","display_name":"Mart\u00edn Cowie","orcid":"https://orcid.org/0000-0001-7457-2552","observed_orcids":["https://orcid.org/0000-0001-7457-2552"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Martin R Cowie","raw_affiliation_strings":["National Heart and Lung Institute, Imperial College London, London, UK","National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Heart and Lung Institute, Imperial College London, London, UK","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK","institution_ids":["https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5088713964"],"corresponding_institution_ids":["https://openalex.org/I47508984"],"apc_list":null,"apc_paid":null,"fwci":17.2992,"has_fulltext":true,"cited_by_count":130,"citation_normalized_percentile":{"value":0.99454316,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"98","issue":"7","first_page":"573","last_page":"578"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dabigatran-etexilate","display_name":"dabigatran etexilate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9649999737739563},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.8270000219345093},{"id":"https://openalex.org/keywords/systemic-embolism","display_name":"systemic embolism","score":0.9890000224113464},{"id":"https://openalex.org/keywords/oral-anticoagulants","display_name":"oral anticoagulants","score":0.8769999742507935},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9800000190734863},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9100000262260437},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.7609999775886536},{"id":"https://openalex.org/keywords/intracranial-hemorrhage","display_name":"intracranial hemorrhage","score":0.8960000276565552},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.593999981880188},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9703004360198975},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.9441947937011719},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.7689757347106934},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.5999540090560913},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.5926516056060791},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5909143090248108},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.5202099680900574},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45833662152290344},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.42768359184265137},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.4254066050052643},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004617","descriptor_name":"Embolism","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004617","descriptor_name":"Embolism","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004617","descriptor_name":"Embolism","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D058833","descriptor_name":"Antithrombin Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1136/heartjnl-2011-300646","doi":"https://doi.org/10.1136/heartjnl-2011-300646","is_oa":true,"landing_page_url":"https://doi.org/10.1136/heartjnl-2011-300646","pdf_url":"https://heart.bmj.com/content/heartjnl/98/7/573.full.pdf","source":{"id":"https://openalex.org/S191565391","display_name":"Heart","issn_l":"1355-6037","issn":["1355-6037","1468-201X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heart","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2325112","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3308473","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3308473","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3308473/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heart","raw_type":"Text"},{"id":"pmid:22422743","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22422743","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heart (British Cardiac Society)","raw_type":"Comparative Study"},{"id":"pmh:oai:spiral.imperial.ac.uk:10044/1/81280","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10044/1/81280","pdf_url":null,"source":{"id":"https://openalex.org/S4306401396","display_name":"Spiral (Imperial College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I47508984","host_organization_name":"Imperial College London","host_organization_lineage":["https://openalex.org/I47508984"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"578","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1136/heartjnl-2011-300646","doi":"https://doi.org/10.1136/heartjnl-2011-300646","is_oa":true,"landing_page_url":"https://doi.org/10.1136/heartjnl-2011-300646","pdf_url":"https://heart.bmj.com/content/heartjnl/98/7/573.full.pdf","source":{"id":"https://openalex.org/S191565391","display_name":"Heart","issn_l":"1355-6037","issn":["1355-6037","1468-201X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heart","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2096719451.pdf","grobid_xml":"https://content.openalex.org/works/W2096719451.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W962486542","https://openalex.org/W1982179895","https://openalex.org/W1986637035","https://openalex.org/W1993614294","https://openalex.org/W1995044128","https://openalex.org/W1999468381","https://openalex.org/W1999999021","https://openalex.org/W2003219143","https://openalex.org/W2014783633","https://openalex.org/W2022239683","https://openalex.org/W2029640576","https://openalex.org/W2044345205","https://openalex.org/W2047926237","https://openalex.org/W2066157763","https://openalex.org/W2079179133","https://openalex.org/W2083828641","https://openalex.org/W2085270509","https://openalex.org/W2086295893","https://openalex.org/W2090225839","https://openalex.org/W2092923655","https://openalex.org/W2095783086","https://openalex.org/W2097156473","https://openalex.org/W2113446992","https://openalex.org/W2129155820","https://openalex.org/W2136489990","https://openalex.org/W2164861810","https://openalex.org/W2169473952","https://openalex.org/W2230199620","https://openalex.org/W4236713090","https://openalex.org/W4242564861"],"related_works":["https://openalex.org/W2083828641","https://openalex.org/W2292929634","https://openalex.org/W2030619174","https://openalex.org/W7098363475","https://openalex.org/W1987556610","https://openalex.org/W2141443241","https://openalex.org/W2541580365","https://openalex.org/W2122348080","https://openalex.org/W4241187328","https://openalex.org/W1979708394"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"assess":[2],"the":[3,18,37,66,145,172,181,217,227],"cost-effectiveness":[4,38,87,161],"of":[5,20,39,55,160,166,219,229],"dabigatran":[6,40,94,101,115,128,148,189,220],"etexilate,":[7],"a":[8,73,158,223],"new":[9],"oral":[10],"anticoagulant,":[11],"versus":[12,42,155,183],"warfarin":[13,156],"and":[14,22,57,85,106,111,142,152,168,188,197,231],"other":[15],"alternatives":[16],"for":[17,147,226],"prevention":[19,228],"stroke":[21,230],"systemic":[23,232],"embolism":[24,233],"in":[25,63,208,239],"UK":[26,67,241],"patients":[27,136,242],"with":[28,51,65,93,130,157,201,243],"atrial":[29],"fibrillation":[30],"(AF).":[31],"METHODS:":[32],"A":[33],"Markov":[34],"model":[35],"estimated":[36],"etexilate":[41,95,102,116,129,149,190,221],"warfarin,":[43],"aspirin":[44,131,184],"or":[45,132],"no":[46,133,202],"therapy.":[47,134,203],"Two":[48],"patient":[49,173],"cohorts":[50],"AF":[52],"(starting":[53],"age":[54],"<80":[56,141,179],"\u226580":[58,143],"years)":[59],"were":[60,125,150,206],"considered":[61],"separately,":[62],"line":[64],"labelled":[68],"indication.":[69],"Modelled":[70],"outcomes":[71],"over":[72],"lifetime":[74],"horizon":[75],"included":[76],"clinical":[77],"events,":[78],"quality-adjusted":[79],"life":[80],"years":[81],"(QALYs),":[82],"total":[83],"costs":[84],"incremental":[86],"ratios":[88],"(ICERs).":[89],"RESULTS:":[90],"Patients":[91],"treated":[92],"experienced":[96],"fewer":[97,107],"ischaemic":[98],"strokes":[99,113],"(3.74":[100],"vs":[103,117],"3.97":[104],"warfarin)":[105,119],"combined":[108],"intracranial":[109],"haemorrhages":[110],"haemorrhagic":[112],"(0.43":[114],"0.99":[118],"per":[120],"100":[121],"patient-years.":[122],"Larger":[123],"differences":[124],"observed":[126],"comparing":[127],"For":[135,171],"initiating":[137],"treatment":[138,176,225],"at":[139,162,177],"ages":[140,178],"years,":[144,180],"ICERs":[146],"\u00a34831":[151],"\u00a37090/QALY":[153],"gained":[154,165,187],"probability":[159],"\u00a320":[163],"000/QALY":[164],"98%":[167],"63%,":[169],"respectively.":[170],"cohort":[174],"starting":[175],"ICER":[182],"was":[185,191,194],"\u00a33457/QALY":[186],"dominant":[192],"(ie,":[193],"less":[195],"costly":[196],"more":[198],"effective)":[199],"compared":[200],"These":[204],"results":[205],"robust":[207],"sensitivity":[209],"analyses.":[210],"CONCLUSIONS:":[211],"This":[212],"economic":[213],"evaluation":[214],"suggests":[215],"that":[216],"use":[218],"as":[222],"first-line":[224],"is":[234],"likely":[235],"to":[236],"be":[237],"cost-effective":[238],"eligible":[240],"AF.":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2096719451","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":25},{"year":2013,"cited_by_count":39},{"year":2012,"cited_by_count":20}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
